Nanodrop drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (11)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Global impact of unproductive splicing on human gene expression. (2024)
- Detection and analysis of complex structural variation in human genomes across populations and in brains of donors with psychiatric disorders. (2024)
- Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
- Nanopore sequencing and the Shasta toolkit enable efficient de novo assembly of eleven human genomes. (2020)
- Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. (2018)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- Preaxial polydactyly following early gestational exposure to the smoothened agonist, SAG, in C57BL/6J mice. (2017)
- Spatial reconstruction of single-cell gene expression data. (2015)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| nanodrop | drug | 29 | 29 |
| nanodrop technologies | drug | 2 | 2 |
| nanodrop® | drug | — | — |